Is GlobalFoundries On The Verge Of A Breakout?
GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…
Sell
45
VNDA Quote, Financials, Valuation and Earnings
Last price:
$4.44
Seasonality move
:
84.65%
Day range:
$4.37 - $4.53
52-week range:
$3.81 - $6.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.25x
P/B ratio:
0.50x
Volume:
548.4K
Avg. volume:
596K
1-year change:
-15.75%
Market cap:
$254M
Revenue:
$198.8M
EPS (TTM):
-$0.75
Vanda Pharmaceuticals SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
VNDA
Vanda Pharmaceuticals
|
05/09/2024 | 10-Q | 10-Q filing on 05/09/2024 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/09/2023 | 10-Q | 10-Q filing on 11/09/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2023 | 10-Q | 10-Q filing on 07/28/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2023 | 10-Q | 10-Q filing on 05/03/2023 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2022 | 10-Q | 10-Q filing on 11/03/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2022 | 10-Q | 10-Q filing on 05/06/2022 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2021 | 10-Q | 10-Q filing on 11/04/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/06/2021 | 10-Q | 10-Q filing on 05/06/2021 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
10/29/2020 | 10-Q | 10-Q filing on 10/29/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/06/2020 | 10-Q | 10-Q filing on 08/06/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/26/2020 | 10-K | 10-K filing on 02/26/2020 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2019 | 10-Q | 10-Q filing on 11/07/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2019 | 10-Q | 10-Q filing on 05/03/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/19/2019 | 10-K | 10-K filing on 02/19/2019 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/02/2018 | 10-Q | 10-Q filing on 08/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/02/2018 | 10-Q | 10-Q filing on 05/02/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/15/2018 | 10-K | 10-K filing on 02/15/2018 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/03/2017 | 10-Q | 10-Q filing on 05/03/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/17/2017 | 10-K | 10-K filing on 02/17/2017 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/03/2016 | 10-Q | 10-Q filing on 11/03/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/28/2016 | 10-Q | 10-Q filing on 07/28/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
05/05/2016 | 10-Q | 10-Q filing on 05/05/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
02/12/2016 | 10-K | 10-K filing on 02/12/2016 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
11/04/2015 | 10-Q | 10-Q filing on 11/04/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
07/31/2015 | 10-Q | 10-Q filing on 07/31/2015 | View Form |
|
VNDA
Vanda Pharmaceuticals
|
06/10/2015 | 10-K | 10-K filing on 06/10/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Dick’s Sporting Goods Buying Foot Locker Smart?
Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…
Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
55
RGC alert for May 21
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Buy
64
AKRO alert for May 21
Akero Therapeutics [AKRO] is up 24.59% over the past day.
Buy
76
AGYS alert for May 21
Agilysys [AGYS] is up 22.13% over the past day.
